Researchers examined the effects of metformin on adults with type 2 diabetes and chronic kidney disease, congestive heart failure, or chronic liver disease with hepatic impairment on mortality.
In a recent study, researchers sought to quantify the relationship between absence of hypertension, obesity, and diabetes in midlife and risk of incident heart failure events.
In a recent study commissioned by the USPSTF, researchers reviewed the benefits and harms of statin therapy for the prevention of cardiovascular disease in adults at increased CVD risk but without prior CVD...
Diets high in monounsaturated fatty acids reduced central obesity and were associated with improved metabolic syndrome risk scores compared with diets high in polyunsaturated fatty acids, according to a...
In a recent study, researchers sough to reevaluate the association of high-density lipoprotein cholesterol level with cardiovascular and non-cardiovascular mortality risk.
Although minorities are often affected by CVD risk factors, cultural differences can act as barriers to care. Alexander R. Green, MD, highlighted the barriers to hypertension management and how to overcome...
Errors in at-home or in-office BP measurement can affect the reading’s results, which in turn can impact BP management. At Consultant360’s Cardiometabolic Risk Summit 2019, F. Wilford Germino, MD, provided...
New research finds that patients with pacemakers or implantable cardioverter-defibrillators (ICDs) who experience brief episodes of atrial tachyarrhythmia are not at greater risk of stroke or other clinical...
CMHC provides a single point of access for busy practitioners to stay abreast of evolving science, clinical practice advances and continuing education in cardiometabolic disease prevention and management.
...
